AAAAAA

   
Results: 1-9 |
Results: 9
Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge
Authors: Stangier, J Su, CAPF van Heiningen, PNM Meinicke, T van Lier, JJ de Bruin, H Tamminga, WJ Jonkman, JHG
Citation: J. Stangier et al., Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge, J CARDIO PH, 38(5), 2001, pp. 672-685
Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients
Authors: Stangier, J Su, CAPF Roth, W
Citation: J. Stangier et al., Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients, J INT MED R, 28(4), 2000, pp. 149-167
Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteers
Authors: Stangier, J Su, CAPF Hendriks, MGC van Lier, JJ Sollie, FAE Oosterhuis, B Jonkman, JHG
Citation: J. Stangier et al., Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteers, J CLIN PHAR, 40(12), 2000, pp. 1331-1337
Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers
Authors: Stangier, J Su, CAPF Fraunhofer, A Tetzloff, W
Citation: J. Stangier et al., Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers, J CLIN PHAR, 40(12), 2000, pp. 1338-1346
Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers
Authors: Stangier, J Su, CAPF
Citation: J. Stangier et Capf. Su, Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers, J CLIN PHAR, 40(12), 2000, pp. 1347-1354
Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers
Authors: Stangier, J Su, CAPF Schondorfer, G Roth, W
Citation: J. Stangier et al., Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers, J CLIN PHAR, 40(12), 2000, pp. 1355-1364
Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: Comparison withhealthy volunteers
Authors: Stangier, J Su, CAPF Brickl, R Franke, H
Citation: J. Stangier et al., Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: Comparison withhealthy volunteers, J CLIN PHAR, 40(12), 2000, pp. 1365-1372
The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers
Authors: Stangier, J Su, CAPF Hendriks, MGC van Lier, JJ Sollie, FAE Oosterhuis, B Jonkman, JHG
Citation: J. Stangier et al., The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers, J CLIN PHAR, 40(12), 2000, pp. 1373-1379
Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers
Authors: Hatorp, V Oliver, S Su, CAPF
Citation: V. Hatorp et al., Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers, INT J CL PH, 36(12), 1998, pp. 636-641
Risultati: 1-9 |